Barrington, Illinois Clinical Trials

A listing of Barrington, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 72 clinical trials
Study to Explore the Efficacy and Safety of BIO89-100 in Subjects With Severe Hypertriglyceridemia

This study is designed to assess the efficacy, safety, and tolerability of different doses and dose regimens (QW or every 2 weeks [Q2W]), subcutaneous (SC) dosing of BIO89-100 compared to placebo in subjects with Severe Hypertriglyceridemia (SHTG).

Family Medicine Specialists, Inc.
 (7.5 away) Contact site
  • 05 Jun, 2021
  • +39 other locations
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days …

AMITA Health - Alexian Brothers Neurosciences Institute Clinical Research
 (7.2 away) Contact site
  • 26 Sep, 2021
  • +79 other locations
A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis

The purpose of this study is to evaluate the efficacy and safety of bermekimab in participants with moderate to severe atopic dermatitis (AD).

topical agents
Arlington Dermatology
 (9.0 away) Contact site
  • 10 Sep, 2021
  • +50 other locations
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy

Psoriasis (PsO) is a chronic disease characterized by marked inflammation of the skin that results in thick, red, scaly plaques. This study will assess how safe and effective risankizumab is compared to apremilast in adult participants with moderate plaque psoriasis. Adverse events and change in disease symptoms will be monitored. …

systemic therapy
plaque psoriasis
Arlington Dermatology /ID# 228945
 (9.0 away) Contact site
  • 24 Sep, 2021
  • +66 other locations
Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

The primary objective is to evaluate the efficacy and safety of efavaleukin alfa in subjects with active SLE.

Greater Chicago Specialty Physicians
 (7.1 away) Contact site
  • 24 Sep, 2021
  • +66 other locations
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis (RA) is an inflammatory disease of the joints causing pain, stiffness, swelling and loss of joint function. This study evaluates how safe and effective ABBV-154 is in participants treated for moderately to severely active RA. Adverse events and change in the disease activity will be assessed. ABBV-154 is …

Greater Chicago Specialty Physicians /ID# 228282
 (7.1 away) Contact site
  • 22 Sep, 2021
  • +314 other locations
Study to Assess the Safety and Efficacy of ONZETRA Xsail for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents

This study will be conducted to evaluate the safety and efficacy of sumatriptan nasal powder (AVP-825) compared to placebo in the acute treatment of migraine in adolescent participants, 12 through 17 years of age.

St. Alexius Medical Center
 (7.9 away) Contact site
  • 25 Mar, 2021
  • +41 other locations
Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study

This Phase 3 study will evaluate APP13007 in comparison to the matching vehicle placebo in a randomized, parallel-group, double-masked fashion. The subjects will have undergone routine cataract surgery on Day 0 of the study and will be assessed the next day (Post-operative Day; POD1) after uncomplicated surgery for eligibility for …

Chicago Cornea Consultants
 (7.9 away) Contact site
  • 01 Sep, 2021
  • +29 other locations
Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)

This study will assess the safety and efficacy of ARQ-154 foam vs vehicle applied once daily for 8 weeks by subjects with scalp and body psoriasis.

Arcutis Biotherapeutics Clinical Site 10
 (8.6 away) Contact site
  • 18 Sep, 2021
  • +2 other locations
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

To evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of adjunctive treatment in subjects with schizophrenia

adjunctive treatment
Alexian Brothers Center for Psychiatric Research
 (7.2 away) Contact site
  • 29 Jan, 2021
  • +151 other locations